Kahira Pharmaceuticals & Chemical Industries Company reported unaudited earnings results for the first half of fiscal year 2019/2020. For the period, the company's net profits amounted to EGP 56.77 million in the six-month period ended 31 December 2019, compared to EGP 43.9 million in the year-ago period. Meanwhile, sales grew to EGP 513.16 million from EGP 503.18 million in the corresponding period a year earlier.